Table 1.
Clinical Characteristics of the Patients According to LMR and Hemoglobin in the Training Group
| Characteristic | LMR | P value | Hemoglobin | P value | |||
|---|---|---|---|---|---|---|---|
| All | High Group | Low Group | High Group | Low Group | |||
| Patients | N=271 | N=72 | N=221 | N=122 | |||
| Age categorized, y | 0.873 | 0.003 | |||||
| ≤65 | 255 (74.3) | 202 (74.5) | 53 (73.6) | 176 (79.6) | 79 (64.8) | ||
| >65 | 88 (25.7) | 69 (25.5) | 19 (26.4) | 45 (20.4) | 43 (35.2) | ||
| Gender | 0.876 | 0.116 | |||||
| Male | 226 (65.9) | 178 (65.7) | 48 (66.7) | 139 (62.9) | 87 (71.3) | ||
| Female | 117 (34.1) | 93 (34.3) | 24 (33.3) | 82 (37.1) | 35 (28.7) | ||
| BMI categorized, kg/m2 | 0.169 | 0.011 | |||||
| <25 | 185 (53.9) | 141 (52.0) | 44 (61.1) | 108 (48.9) | 77 (63.1) | ||
| ≥25 | 158 (46.1) | 130 (48.0) | 28 (38.9) | 113 (51.1) | 45 (36.9) | ||
| Hypertension | 0.980 | 0.262 | |||||
| No | 191 (55.7) | 151 (55.7) | 40 (55.6) | 128 (57.9) | 63 (51.6) | ||
| Yes | 152 (44.3) | 120 (44.3) | 32 (44.4) | 93 (42.1) | 59 (48.4) | ||
| Diabetes | 0.844 | 0.863 | |||||
| No | 288 (84.0) | 227 (83.8) | 61 (84.7) | 185 (83.7) | 103 (84.4) | ||
| Yes | 55 (16.0) | 44 (16.2) | 11 (15.3) | 36 (16.3) | 19 (15.6) | ||
| Cardiovascular diseases | 0.697 | 0.659 | |||||
| No | 300 (87.5) | 238 (87.8) | 62 (86.1) | 192 (86.9) | 108 (88.5) | ||
| Yes | 43 (12.5) | 33 (12.2) | 10 (13.9) | 29 (13.1) | 14 (11.5) | ||
| Smoking | 0.469 | 0.601 | |||||
| No | 286 (83.4) | 228 (84.1) | 58 (80.6) | 186 (84.2) | 100 (82.0) | ||
| Yes | 57 (16.6) | 43 (15.9) | 14 (19.4) | 35 (15.8) | 22 (18.0) | ||
| Surgery type | <0.001 | <0.001 | |||||
| Partial nephrectomy | 187 (54.5) | 168 (62.0) | 19 (26.4) | 148 (67.0) | 39 (32.0) | ||
| Radical nephrectomy | 156 (45.5) | 103 (38.0) | 53 (73.6) | 73 (33.0) | 83 (68.0) | ||
| Laterality | 0.615 | 0.968 | |||||
| Left | 171 (49.9) | 134 (49.4) | 38 (52.8) | 110 (49.8) | 61 (50.0) | ||
| Right | 172 (50.1) | 137 (50.6) | 34 (47.2) | 111 (50.2) | 61 (50.0) | ||
| AJCC stage | <0.001 | <0.001 | |||||
| I | 256 (74.6) | 220 (81.2) | 36 (50.0) | 183 (82.8) | 73 (59.8) | ||
| II | 19 (5.5) | 10 (3.7) | 9 (12.5) | 10 (4.5) | 9 (7.4) | ||
| III | 45 (13.1) | 29 (10.7) | 16 (22.2) | 18 (8.1) | 27 (22.1) | ||
| IV | 23 (6.7) | 12 (4.4) | 11 (15.3) | 10 (4.5) | 13 (10.7) | ||
| T-stage | <0.001 | <0.001 | |||||
| T1 | 260 (75.8) | 223 (82.3) | 37 (51.4) | 185 (83.7) | 75 (61.5) | ||
| T2 | 23 (6.7) | 13 (4.8) | 10 (13.9) | 12 (5.4) | 11 (9.0) | ||
| T3 | 51 (14.9) | 28 (10.3) | 23 (31.9) | 17 (7.7) | 34 (27.9) | ||
| T4 | 9 (2.6) | 7 (2.6) | 2 (2.8) | 7 (3.2) | 2 (1.6) | ||
| N-stage | 0.613 | 0.010 | |||||
| N0 | 330 (96.2) | 260 (95.9) | 70 (97.2) | 217 (98.2) | 113 (92.6) | ||
| N1 | 13 (3.8) | 11 (4.1) | 2 (2.8) | 4 (1.8) | 9 (7.4) | ||
| M-stage | <0.001 | 0.005 | |||||
| M0 | 327 (95.3) | 264 (97.4) | 63 (87.5) | 216 (97.7) | 111 (91.0) | ||
| M1 | 16 (4.7) | 7 (2.6) | 9 (12.5) | 5 (2.3) | 11 (9.0) | ||
| Fuhrman grade | 0.004 | 0.001 | |||||
| I | 55 (16.0) | 47 (17.3) | 8 (11.1) | 44 (19.9) | 11 (9.0) | ||
| II | 216 (63.0) | 176 (64.9) | 40 (55.6) | 136 (61.5) | 80 (65.6) | ||
| III | 64 (18.7) | 45 (16.6) | 19 (26.4) | 40 (18.1) | 24 (19.7) | ||
| IV | 8 (2.3) | 3 (1.1) | 5 (6.9) | 1 (0.5) | 7 (5.7) | ||
Abbreviations: LMR, lymphocyte to monocyte ratio; BMI, body mass index; AJCC, American Joint Committee on Cancer.